Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSK’s Witty Looks To Biotech Model In R&D Retool; Mini Labs Will Bid For Project Funding

This article was originally published in The Pink Sheet Daily

Executive Summary

Planned units include five to 80 scientists, operate within the CEDDs program.

You may also be interested in...



How GSK Is Driving Early Stage Research In Its DPUs

Most of GlaxoSmithKline's early stage research organizations, discovery performance units, survive a three-year review cycle, with co-localization, monetary incentives and career support leading a change of culture.

Incentives And Less Fear Of Failure: How GSK Is Driving Early-Stage Research In Its DPUs

Most of GlaxoSmithKline's early-stage research organizations, discovery performance units, survive a three-year review cycle, with co-localization, monetary incentives and career support leading a change of culture.

Glaxo's Strategy For Drug Performance Units Is Showing Promise, Slaoui Says

R&D Chairman Moncef Slaoui provides update on drug performance units one year out at Windhover's Pharmaceutical Strategic Alliance Conference.

Related Content

Topics

UsernamePublicRestriction

Register

PS068130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel